Research in this area has gained momentum, particularly in the context of diabetes treatment, as scientists explore innovative methods to generate, preserve, and transplant islet cells.

A groundbreaking stem cell therapy offers new hope for type 1 diabetes, with early results showing potential for insulin ...

The Global Stem Cell Therapy For Diabetes Related Conditions market industry is primarily driven by the continuous advancements in technology.

Three people with type 1 diabetes who received Vertex Pharma’s islet cell therapy VX-880 have been able to come off insulin altogether within a year, raising the prospect of a life without ...

Initial results of Sana Biotechnology’s new gene-editing technique demonstrate that transplanted islet cells successfully produced insulin in one individual with type 1 diabetes – without the need for ...

We view the insights from the current study as directly applicable to developing SC451, our HIP-modified, stem cell-derived pancreatic islet cell program for the treatment of type 1 diabetes.

The final, formatted version of the article will be published soon. Diabetes mellitus (DM) is a global health crisis affecting millions, with islet transplantation emerging as a promising treatment ...

(NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced initial results from an investigator-sponsored, first-in-human study transplanting ...

Emirates Health Services (EHS) takes the spotlight at the Arab Health 2025 expo in Dubai, introducing pioneering projects ...

Emirates Health Services EHS takes centre stage at Arab Health 2025 medical expo showcasing a series of groundbreaking ...

First-in-Human Study Provides Evidence that Sana’s Hypoimmune (HIP) Technology Enables Transplanted Islet Cells to Avoid ... Treated Patient with Type 1 Diabetes ...